
Invasive species cost trillions in damages: study
A wild boar runs over a glade in a forest in the Taunus region near Frankfurt, Germany, Friday, Nov. 9, 2019. (AP Photo/Michael Probst)
Paris, France — From river-clogging plants to disease-carrying insects, the direct economic cost of invasive species worldwide has averaged about US$35 billion a year for decades, researchers said Monday.
Since 1960, damage from non-native plants and animals expanding into new territory has cost society more than $2.2 trillion, 17 times higher than previous estimates, they reported in the journal Nature Ecology & Evolution.
The accelerating spread of invasive species -- from mosquitoes to wild boar to tough-to-eradicate plants -- blights agriculture, spreads disease and drives the growing pace of species extinction.
Earlier calculations based on highly incomplete data were already known to fall far short of reality.
To piece together a more accurate picture, an international team of researchers led by Ismael Soto, a scientist at the University of South Bohemia in the Czech Republic, compiled data on 162 invasive species whose costs have been well documented in at least a handful of countries.
They then modelled the economic impact for 78 other countries such as Bangladesh and Costa Rica, for which no data was previously available.
'We expected an underestimation of invasion costs, but the magnitude was striking,' Soto told AFP.
Due mainly to high volumes of trade and travel, tens of thousands of animal and plant species have taken root, sometimes literally, far from their places of origin.
Europe is by far the continent most affected by the phenomenon, followed by North America and Asia.
'Plants were the most economically damaging group, both for damage and management,' Soto said. 'Cost hotspots include urban coastal areas, notably in Europe, eastern China, and the US.'
Animals can cause devastating damage too.
Wild boar, for example, destroy crops, cornfields and vineyards, while mosquitoes -- with expanding ranges due to global warming -- impose direct costs to human health by spreading diseases such as dengue and malaria.
Another example is Japanese knotweed, an invasive plant that is very common in Europe and requires costly eradication programmes.
'Our study is based on only 162 species,' Soto noted. 'Our figure is probably still an underestimate of a wider problem, and therefore the real economic costs could be even higher.'
Using a broader definition -- including indirect costs such as lost income -- the UN's biodiversity expert group, IPBES, has calculated the total cost to society of invasive species at about $400 billion annually.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
8 hours ago
- Globe and Mail
Bristol Myers Collaborates With BNTX for Oncology Candidate
BMY announced a strategic collaboration agreement with BioNTech BNTX. Both companies have entered into an agreement for the global co-development and co-commercialization of BioNTech's investigational bispecific antibody BNT327 across numerous solid tumor types. BNT327 is a novel investigational bispecific antibody combining two complementary, validated mechanisms in oncology into a single molecule. Shares of BNTX surged on the deal announcement. Shares of Bristol Myers lost 12.8% year to date compared with the industry 's decline of 2.2%. More on BMY & BNTX Agreement Per the terms, BMY and BNTX will jointly develop and commercialize BNT327, including the development of BNT327 as monotherapy and in combination with other products. Both BMY and BNTX own the right to develop BNT327 independently in further indications and combinations, including combinations of BNT327 with proprietary pipeline assets. Per the terms, BMY will make an upfront payment of $1.5 billion to BioNTech. In addition, BNTX will also receive $2 billion in non-contingent anniversary payments through 2028. BioNTech is also eligible to receive up to $7.6 billion in additional development, regulatory and commercial milestones. Both the companies will jointly share development and manufacturing costs along with profits on an equal basis. BNT327, a next-generation bispecific antibody candidate, targets PD-L1 and VEGF-A. It is currently being evaluated in multiple ongoing trials with more than 1,000 patients treated to date, including phase III studies with registrational potential evaluating BNT327 as first-line treatment in extensive stage small cell lung cancer (ES-SCLC) and non-small cell lung cancer (NSCLC). A phase III study evaluating the candidate in triple negative breast cancer (TNBC) is planned to start by the end of 2025. Data from ongoing trials (on a preliminary basis) underscore the potential for combining anti-PD-L1 and anti-VEGF-A – two well-established therapeutic targets – into a single molecule to deliver synergistic clinical benefits for patients across multiple tumor types. BMY Looks to Diversify Business BMY is depending on newer drugs like Opdualag, Reblozyl and Breyanzi to stabilize its revenue base as its legacy drugs face generic competition. BMY earlier won FDA approval for xanomeline and trospium chloride (formerly KarXT), an oral medication for the treatment of schizophrenia, in adults, under the brand name Cobenfy. The approval broadens BMY's portfolio. Cobenfy represents the first new pharmacological approach to treating schizophrenia in decades. This drug is expected to contribute meaningfully to BMY's top line in the coming years. BMY has experienced a few pipeline setbacks in recent months, which negatively impacted its share price. The late-stage ODYSSEY-HCM study evaluating cardiovascular drug Camzyos for the treatment of adult patients with symptomatic New York Heart Association (NYHA) class II-III non-obstructive hypertrophic cardiomyopathy did not meet its dual primary endpoints. The top-line results from the phase III ARISE study on schizophrenia drug Cobenfy were also disappointing. The study is evaluating the efficacy and safety of the drug as an adjunctive treatment to atypical antipsychotics in adults with inadequately controlled symptoms of schizophrenia. Developing bispecific antibodies that target two proteins, namely PD-1 and VEGF, has lately been one of the lucrative areas in cancer treatment. In November, Merck signed a deal with China-based LaNova Medicines for the latter's PD-1xVEGF targeting bispecific antibody candidate, LM-299. The latest entrant into this space is Pfizer PFE, which recently entered a multi-billion-dollar deal with Chinese biotech 3SBio for the latter's PD-1/VEGF bispecific antibody SSGJ-707. The deal is expected to be complete in third-quarter 2025. BMY's Zacks Rank & Stocks to Consider Bristol Myers currently carries a Zacks Rank #3 (Hold). A couple of better-ranked stocks in the pharma/biotech sector are Novartis NVS and Pfizer, both carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. The Zacks Consensus Estimate for Novartis' 2025 earnings per share (EPS) has risen from $8.47 to $8.74 over the past 60 days. EPS estimates for 2026 have jumped 20 cents to $9.02 during this timeframe. The stock has risen 18.6% so far this year. Pfizer's 2025 EPS estimate has risen from $2.97 to $3.06 in the past 60 days, while that for 2026 has gone up from $2.99 to $3.09 over the same timeframe. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months. Free: See Our Top Stock And 4 Runners Up Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Novartis AG (NVS): Free Stock Analysis Report Bristol Myers Squibb Company (BMY): Free Stock Analysis Report Pfizer Inc. (PFE): Free Stock Analysis Report BioNTech SE Sponsored ADR (BNTX): Free Stock Analysis Report

National Post
13 hours ago
- National Post
NatureCounts App Launches, Introduces Point Count Technology to Support Bird Conservation
Article content Birds Canada and Punchcard Systems revolutionize how bird populations are tracked and protected with the unveiling of novel point count technology. Article content Article content EDMONTON, Alberta — In response to the stark decline of bird populations in North America, Birds Canada, working together with Punchcard Systems, has officially launched the NatureCounts mobile app, an intuitive digital tool that empowers conservationists, scientists, and volunteers to collect data faster, more accurately, and at greater scale than ever before. Article content Collapsing bird numbers show no signs of stopping. Since 1970, North America has lost nearly 3 billion birds. In Canada alone, well over a third of bird species have declined over the same period, according to the 2024 State of Canada's Birds Report. Birds play a critical role in healthy ecosystems, and their populations signal broader environmental changes, making their decline a warning sign for biodiversity at large and creating an immediate need for better tools to understand which species are at risk, why they are declining, and how to act swiftly. Article content 'With bird populations in crisis, we need better data and faster action,' said Catherine Jardine, Associate Director of Data Science and Technology at Birds Canada. 'NatureCounts makes that possible by empowering Citizen Scientists, researchers, and volunteers to collect high-quality information and drive urgent, informed decisions to protect our birds and our ecosystems.' Article content At the core of the new NatureCounts app is the point count interface, a one-of-a-kind tool that digitizes one of the most critical and widely used bird monitoring methods in conservation science. By integrating satellite imagery, precise GPS mapping, and a mobile-first design, the new point count tool replaces a traditionally paper-based, time-intensive process with an intuitive, efficient, and scalable solution. Early trials show the technology has already saved over five years' worth of manual data entry, freeing up valuable time for analysis and action. Article content 'At Punchcard, we're proud to partner with organizations tackling urgent, real-world challenges, and Birds Canada is a perfect example,' said Sam Jenkins, Managing Partner at Punchcard Systems. 'This collaboration brought together deep field expertise and thoughtful technology design to strengthen, not replace, traditional conservation methods. NatureCounts represents a powerful step forward in global conservation, and we're proud to support Birds Canada in leading that charge.' Article content Key features of the NatureCounts app include: Article content Mobile-first data collection: Designed for smartphones and tablets, the NatureCounts app enables users to capture detailed observations in the field, even offline. GPS and satellite-enabled interface: Interactive mapping ensures accurate geolocation and route planning for repeatable surveys. Flexible protocol customization: Supports more than 80 biodiversity monitoring programs, including regional, national, and international standards. Offline functionality: Built for use in remote and rugged environments with no cell signal. Article content Tens of thousands of individuals in North America are already contributing data through Birds Canada programs. Early adopters of NatureCounts in the United States, including the Pennsylvania Bird Atlas, are reporting transformative improvements in data quality and efficiency. As adoption grows, NatureCounts is poised to support international conservation efforts, including national biodiversity strategies, environmental policy, and species assessments. Article content 'When we started planning the Pennsylvania Bird Atlas point counts, it quickly became apparent that all other existing tools lacked crucial features,' said Amber Wiewel, Coordinator of the Pennsylvania Bird Atlas. 'The NatureCounts mobile app has been the perfect solution for our needs, and I am so impressed with the new point count feature. It's intuitive, efficient, and exactly what we needed to properly collect and manage this critical data.' Article content Birds Canada and Punchcard Systems continue to enhance the platform with new features and improvements planned for 2025 and beyond. Article content About Birds Canada Birds Canada is a national charitable organization whose mission is to drive action to increase the understanding, appreciation, and conservation of birds in Canada. Through its many citizen science programs, research projects, and conservation initiatives, Birds Canada generates and uses an enormous amount of conservation data to help protect birds. Article content About Punchcard Punchcard Systems is a Canadian digital transformation innovation consultancy that helps organizations turn complex problems into purposeful, human-centred software solutions. Founded in 2016 by Sam Jenkins and Estyn Edwards, Punchcard was built on the belief that software should be a catalyst for growth, not a hurdle. Recognized as one of Canada's Top Growing Companies by The Globe and Mail, Punchcard partners with over 250 clients across Canada and the U.S., and continues to push the boundaries of what thoughtful technology can do for business, community, and society. Article content Article content Article content Article content Article content Contacts Article content Article content Article content


CTV News
6 days ago
- CTV News
Saving endangered turtles and bats focus of new Toronto Zoo partnership
The Toronto Zoo announces a new partnership to preserve biodiversity in the province. CTV's Beth Macdonell reports. A new partnership at the Toronto Zoo is prioritizing nine Canadian endangered species with the aim of growing of their populations. A five-year, $3-million joint commitment between the zoo and the Nuclear Waste Management Organization (NWMO) will allow critical work to continue to save Blanding's turtles and eight bat species. The goal is to reverse biodiversity loss which is critical to healthy ecosystems. Toby Thorne, supervisor of species recovery at Toronto Zoo, compared the importance of preserving species to a well-functioning clock. 'If I start throwing cogs away, then it might work for a bit, but at some point, it's going to stop working,' said Thorne. 'We're talking about species today, but were talking about preserving biodiversity as a whole, which humans are a part of, and we need that as much as it needs us.' The funding will help continue a turtle raising program at the zoo that works to restore populations hurt by habitat loss, road deaths, and climate change. For the past 12 years, staff have been collecting Blanding's turtles eggs, caring for them while they grow for two years, and releasing them back into the wild. In the 1990s, Blanding's turtles were virtually extinct in the Greater Toronto Area spanning Rouge Valley, with zoo staff saying there were probably less than 10 left in area. But now, thanks to the program, the population is growing. 'They are known as the turtles with the sun under their chin,' explained Thorne. 'They are green overall like most turtles, but they have this bright piece underneath, and they are a nice, smiley turtle.' 'This commitment is a big deal,' added Toronto Zoo CEO Dolf DeJong. When it comes to bats, the partnership is allowing for more research on eight species in Ontario. Seven of those eight bat species are endangered. 'Bats play a critical ecological role, whether it's hunting insects at night,' DeJong said. '[They are] a key piece of the balance, and if you lose one piece, and you lose that balance, I think people only realize the impact of that balance when it's gone.' DeJong said diverse ecosystems are strong ecosystems, and the partnership will help Blanding's turtles and the eight bat species not only survive, but thrive.